While GLP-1 receptor agonists have surged in popularity as miracle treatments for Type 2 diabetes and weight loss, a new report highlights a critical complication for a specific subset of patients: those living with Ehlers-Danlos Syndrome (EDS). According to an analysis published by The Middle Aged Zebra (TMAZ), the very mechanism that makes drugs like […] Double-Edged Sword: Popular Weight Loss Shots Pose Unique Risks For EDS Community ...read more read less